Vaccination and Developments

An HIV vaccine may have the purpose of protecting individuals who do not have HIV from being infected with the virus -a preventative vaccine or treating an HIV-infected person -a therapeutic vaccine. There are two approaches to an HIV vaccine,

  • An active vaccine aims to induce an immune response against HIV
  • A passive vaccine preforms antibodies against HIV are administered

The vaccine candidate was shown to protect monkeys from simian-human immunodeficiency virus (SHIV), an HIV-like virus that only affects monkeys. While we haven’t yet seen the development of a definitive HIV vaccine, this research is having a ripple effect in the field. HIV vaccine candidate induced robust and comparable immune responses in humans and monkeys. Moreover, the vaccine provided 67 percent protection against viral challenge in monkeys.

 

 

  • Track 1-1 Gardasil-9 HPV- Merck vaccine
  • Track 2-2 Experimental attenuated and inactivated herpes vaccines
  • Track 3-3 Candidate HIV vaccines
  • Track 4-4 HIV-1 vaccine regimen- The Lancet

Related Conference of Infectious Diseases